Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 16, 2022

SELL
$101.96 - $128.34 $79,426 - $99,976
-779 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$106.37 - $130.68 $80,628 - $99,055
758 Added 3609.52%
779 $101,000
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $3,396 - $4,050
-33 Reduced 61.11%
21 $2,000
Q2 2021

Jul 29, 2021

SELL
$83.84 - $104.76 $2,515 - $3,142
-30 Reduced 35.71%
54 $6,000
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $3,225 - $3,717
41 Added 95.35%
84 $7,000
Q4 2020

Jan 29, 2021

SELL
$71.69 - $91.23 $5,089 - $6,477
-71 Reduced 62.28%
43 $4,000
Q3 2020

Oct 09, 2020

SELL
$67.19 - $87.44 $134 - $174
-2 Reduced 1.72%
114 $9,000
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $5,293 - $7,079
92 Added 383.33%
116 $8,000
Q1 2020

Apr 13, 2020

SELL
$52.41 - $81.0 $376,565 - $581,985
-7,185 Reduced 99.67%
24 $5,000
Q4 2019

Feb 07, 2020

BUY
$71.7 - $82.09 $516,813 - $591,704
7,208 Added 720800.0%
7,209 $1.68 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $61 - $75
1 New
1 $0
Q4 2017

Feb 13, 2018

SELL
$33.79 - $39.39 $217,742 - $253,829
-6,444 Closed
0 $0
Q3 2017

Oct 11, 2017

BUY
$36.29 - $38.83 $233,852 - $250,220
6,444
6,444 $704,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.